| 1 |
31954752 | Metformin: An old drug against old age and associated morbidities. | 2020 Feb |
1 |
| 2 |
26673006 | Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells. | 2016 Jan 26 |
1 |
| 3 |
26052399 | Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin. | 2015 May 18 |
1 |
| 4 |
23695170 | Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines. | 2013 Jul 1 |
1 |
| 5 |
23707609 | Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways. | 2013 Sep 1 |
3 |
| 6 |
23937224 | Metformin in lung cancer: rationale for a combination therapy. | 2013 Nov |
1 |
| 7 |
24209692 | KSR2 mutations are associated with obesity, insulin resistance, and impaired cellular fuel oxidation. | 2013 Nov 7 |
1 |